← Back to Search

Behavioural Intervention

Text Messaging Intervention for Perinatal Depression (Perinatal TMI Trial)

N/A
Recruiting
Led By Kimberly Yonkers, MD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least age 16
Be younger than 65 years old
Must not have
Blind individuals
In a major depressive episode
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a text-based system that helps pregnant people reduce depression risk w/ tailored messages & evidence-based advice.

Who is the study for?
This trial is for English-speaking individuals at least 16 years old who are pregnant and at risk of depression, as indicated by certain screening scores or a history of depression during pregnancy. Participants must be willing to use a smartphone for text messages but not currently in mental health treatment, living in an institution, planning on terminating the pregnancy, or suffering from panic or substance use disorders.
What is being tested?
The study is testing a text messaging system designed to lower the risk of major depressive episodes in perinatal individuals. It includes tailored texts with links to resources based on Interpersonal Therapy and offers a peer chat feature. The goal is to see if this intervention can help prevent worsening symptoms of depression.
What are the potential side effects?
Since this trial involves receiving text messages rather than medication, traditional physical side effects are not expected. However, participants may experience emotional distress or discomfort related to discussing their feelings or receiving frequent communications about mental health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 16 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am legally blind.
Select...
I am currently experiencing a major depressive episode.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4 for pre-pilot and week 8 for pilot, adjusted for baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 for pre-pilot and week 8 for pilot, adjusted for baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Edinburgh Prenatal Depression Scale
General Self Efficacy Scale
Patient engagement with chat
+2 more
Secondary study objectives
Diagnosis of a major depressive episode
Perlin Mastery Scale
User Engagement Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Text4MomsExperimental Treatment1 Intervention
Texts will include video links that reinforce information relevant to Interpersonal Psychotherapy (IPT).
Group II: Educational ControlActive Control1 Intervention
The control condition will be limited to texts related to pregnancy, nutrition and sleep. We will avoid elements that have behavioral therapeutic effects. Although this condition is meant to constitute time and attention control, we will include material on recognizing depression and links to ways to attain depression treatment and suicide hotline information.

Find a Location

Who is running the clinical trial?

Michigan State UniversityOTHER
198 Previous Clinical Trials
685,200 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,914 Previous Clinical Trials
2,738,535 Total Patients Enrolled
Yale UniversityOTHER
1,920 Previous Clinical Trials
3,031,590 Total Patients Enrolled
~27 spots leftby Dec 2025